Viewing Study NCT02546102


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-04-24 @ 2:55 PM
Study NCT ID: NCT02546102
Status: SUSPENDED
Last Update Posted: 2024-04-03
First Post: 2015-09-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
Sponsor: Precision Life Sciences Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module